A mesodermal stem cell therapy for stroke

stem cell therapy in stroke: a review literature

stroke is an important cause of death in the world and disability world‑wide especially in developed countries. following acute phase of stroke, some procedures and medical treatment such as thrombolytic agents has been recommended; nevertheless many patients have enduring deficits. thus, there is a realistic need to develop treatment strategies for reducing neurological deficits. however, the ...

Inflammation and Stem Cell Therapy for Stroke

Adult stem cell therapy in stroke.

PURPOSE OF REVIEW Acute cerebral infarction causes irreversible locally restricted loss of the neuronal circuitry and supporting glial cells with consecutive functional deficits and disabilities. The currently available and effective therapy targets fast vessel recanalization accompanied by symptomatic measures. Research activities focusing on stem cells, which represent a promising source for ...

stem cell therapy for treatment of epilepsy.

epilepsy as one of the most common neurological disorders affects more than 50 million people worldwide with a higher prevalence rate in low-income countries. excessive electrical discharges in neurons following neural cell damage or loss cause recurrent seizures. one of the most common and difficult to treat types of epilepsy is temporal lobe epilepsy (tle) which results from hippocampal scler...

Adult Stem Cell Therapy for Stroke: Challenges and Progress

Stroke is one of the leading causes of death and physical disability among adults. It has been 15 years since clinical trials of stem cell therapy in patients with stroke have been conducted using adult stem cells like mesenchymal stem cells and bone marrow mononuclear cells. Results of randomized controlled trials showed that adult stem cell therapy was safe but its efficacy was modest, unders...